Spirapril hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for spirapril hydrochloride and what is the scope of patent protection?
Spirapril hydrochloride
is the generic ingredient in one branded drug marketed by Schering and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for spirapril hydrochloride
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Clinical Trials: | 1 |
| Patent Applications: | 408 |
| DailyMed Link: | spirapril hydrochloride at DailyMed |
Recent Clinical Trials for spirapril hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Vigo | Phase 4 |
| King Pharmaceuticals is now a wholly owned subsidiary of Pfizer | Phase 4 |
US Patents and Regulatory Information for spirapril hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-001 | Dec 29, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-003 | Dec 29, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-004 | Dec 29, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for spirapril hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-003 | Dec 29, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
| Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-004 | Dec 29, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
| Schering | RENORMAX | spirapril hydrochloride | TABLET;ORAL | 020240-001 | Dec 29, 1994 | ⤷ Try a Trial | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
